No abstract available
MeSH terms
-
Clinical Decision-Making*
-
Coronary Artery Disease / diagnostic imaging
-
Coronary Artery Disease / mortality
-
Coronary Artery Disease / therapy
-
Hemorrhage / chemically induced
-
Humans
-
Patient Selection
-
Percutaneous Coronary Intervention* / adverse effects
-
Platelet Aggregation Inhibitors* / adverse effects
-
Platelet Aggregation Inhibitors* / therapeutic use
-
Purinergic P2Y Receptor Antagonists / adverse effects
-
Purinergic P2Y Receptor Antagonists / therapeutic use
-
Risk Assessment
-
Risk Factors
-
Ticagrelor* / adverse effects
-
Ticagrelor* / therapeutic use
-
Treatment Outcome
Substances
-
Ticagrelor
-
Platelet Aggregation Inhibitors
-
Purinergic P2Y Receptor Antagonists